Mitsubishi Tanabe Pharma was the original trial sponsor; however Astra Zeneca is now the Responsible Party
2005-09-12
Other
Chronic hepatitis C with compensated cirrhosis
Dainippon Sumitomo Pharma Co., Ltd.
2005-09-12
Other
Chronic obstructive pulmonary disease
Mitsubishi Tanabe Pharma was the original trial sponsor; however Astra Zeneca is now the Responsible Party
2005-09-12
Other
Colorectal cancer
Yakult Honsha Co.,Ltd.
2005-09-12
Other
Colorectal cancer
Yakult Honsha Co.,Ltd.
2005-09-12
Other
Hepatocellular carcinoma
Dainippon Sumitomo Pharma Co., Ltd.
2005-09-12
Other
Involutional osteoporosis
ONO PHARMACEUTICAL CO.,LTD.
2005-09-12
Other
Involutional osteoporosis
ONO PHARMACEUTICAL CO.,LTD.
2005-09-12
Other
Parkinson's disease
Dainippon Sumitomo Pharma Co., Ltd.
2005-09-12
Other
Patients with following chronic hepatitis C (1)Patients with high blood HCV-RNA level (2)Patients who had no efficacy or had relapse after previous monotherapy of interferon preparation